Zimmer Biomet Holdings, INC Form 4 insider transactions

Zimmer Biomet Holdings, Inc. Director Syed A. Jafry increased his beneficial ownership by acquiring additional phantom stock units and restricted stock units on May 29, 2025.

Zimmer Biomet Holdings, Inc. Director Arthur J. Higgins reported the acquisition of phantom stock units and restricted stock units as part of his compensation on May 29, 2025.

Zimmer Biomet Holdings, Inc. Director Robert Hagemann reported the acquisition of 810.46 phantom stock units and 1,404.798 restricted stock units on May 29, 2025, as part of his compensation.

Betsy J. Bernard, a Director at Zimmer Biomet Holdings, Inc., acquired phantom stock units and restricted stock units on May 29, 2025, as part of her compensation.

Zimmer Biomet Holdings, Inc. Director Louis Shapiro reported the acquisition of 810.46 phantom stock units and 1,404.798 restricted stock units on May 29, 2025, as part of his compensation.

Jehanzeb Noor, a Senior Vice President at Zimmer Biomet, acquired 19,875 restricted stock units on April 1, 2025, according to a Form 4 filing.

Director Michael J. Farrell reports acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. under deferred compensation plan.

Director Christopher B. Begley reports the acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. through a deferred compensation plan.

Director Robert Hagemann reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. under the Deferred Compensation Plan for Non-Employee Directors.

Director Arthur J. Higgins reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. under the deferred compensation plan.

Director Maria Teresa Hilado reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. under the deferred compensation plan.

Director Kolli Sreelakshmi reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. under the company's deferred compensation plan.

Director Louis Shapiro reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. through a deferred compensation plan.

Director Devdatt Kurdikar reports acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. under the Deferred Compensation Plan for Non-Employee Directors.

Chad F. Phipps, a Senior VP/General Counsel/Secretary at Zimmer Biomet Holdings, Inc., reported the vesting of restricted stock units and subsequent tax withholding, resulting in changes to his beneficial ownership of company stock.

Mark Bezjak, President, Americas at Zimmer Biomet Holdings, Inc., reports the vesting and disposal of restricted stock units to cover tax obligations.

Paul A. Stellato, VP, Controller & CAO of Zimmer Biomet Holdings, Inc., reports the vesting of restricted stock units and subsequent tax withholding.

Lori Winkler, SVP and CHRO of Zimmer Biomet Holdings, Inc., reports the acquisition and disposal of company stock and restricted stock units.

Wilfred van Zuilen, Group President EMEA at Zimmer Biomet, reports the vesting of restricted stock units and subsequent stock transactions on March 6, 2025.

Zimmer Biomet's President & CEO, Ivan Tornos, reports the vesting of restricted stock units and subsequent stock transactions to cover tax obligations.

Suketu Upadhyay, CFO of Zimmer Biomet Holdings, Inc., reports the vesting of restricted stock units and subsequent tax withholding, resulting in changes to his beneficial ownership of company stock.

Sang Yi, Group President, Asia Pacific at Zimmer Biomet Holdings, Inc., reports the vesting and conversion of restricted stock units into common stock.

Paul A. Stellato, VP, Controller & CAO of Zimmer Biomet Holdings, Inc., acquired 2,458 restricted stock units on February 25, 2025, according to a Form 4 filing with the SEC.

Lori Winkler, SVP and CHRO of Zimmer Biomet Holdings, Inc., reported the acquisition of 7,040 restricted stock units on February 25, 2025, according to a Form 4 filing with the SEC.

Mark Bezjak, President of Americas at Zimmer Biomet, reports acquisition of restricted stock units.

Sang Yi, Group President, Asia Pacific at Zimmer Biomet Holdings, Inc., acquired 8,352 restricted stock units on February 25, 2025, according to a Form 4 filing with the SEC.

Wilfred van Zuilen, Group President, EMEA of Zimmer Biomet Holdings, Inc., reports the acquisition of 9,545 restricted stock units.

Suketu Upadhyay, Exec. VP and CFO of Zimmer Biomet Holdings, Inc., reports the acquisition of 19,090 restricted stock units on February 25, 2025, according to a Form 4 filing with the SEC.

Zimmer Biomet's CEO, Ivan Tornos, reports the acquisition of restricted stock units in the company.

Chad F. Phipps, Sr. VP/Gen Counsel/Secretary of Zimmer Biomet Holdings, Inc., reports the acquisition of 7,875 restricted stock units on February 25, 2025, vesting annually over three years.